About this desk
About TB-500 Get
A paneled reading of the published research — what it is, what it is not, and how it is built.
What this site is
TB-500 Get sets the peer-reviewed research on TB-500 and its parent protein, thymosin beta-4, panel by panel. We read the studies, attribute every quantitative claim to its source, and keep the load-bearing caveats in plain sight — above all, the distinction between the synthetic Ac-LKKTETQ fragment and the full-length protein that most efficacy data actually use.
No exam room stands behind these panels, no clinician is on staff, and no line here is medical guidance. TB-500 Get makes, sells, and supplies nothing — it only reads the published record and cites it.
What the name means
The "get" in the domain is editorial framing — a position this publisher takes relative to the literature and the access question, not a claim about any service we offer. We do not sell TB-500, source it, price it, or help anyone obtain it. When this site discusses access, it does so as general information about how the FDA 503A and 503B compounding framework works, citing FDA, and explicitly not as an offer to supply or as a route to a purchase.
That is why the regulatory page reads like a record rather than a storefront: the honest answer to "how do you get TB-500" is a regulatory one, and we report it as such.
How the digest is built
Every page is built from primary sources — PubMed-indexed studies, ClinicalTrials.gov records, and, for the regulatory material, FDA.gov pages verified against their live text. Findings are reported with their species, dose, and route attached, and animal or in-vitro results are never presented as human ones. Where the literature is thin or null — as it is for the fragment's human efficacy, its validated half-life, and its long-term safety — we say so directly rather than fill the gap.
The goal is a calm, accurate panel of the evidence: a place to see what thymosin beta-4 research has genuinely established, where it has not translated, and what the access record actually says. The full reference list makes the sourcing fully checkable.